Chinese biological medicine start-up JOINN Biologics has raised US$60 million in a series A round of financing led by the country’s private equity investment firm Huagai Capital.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?